CRISPR Therapeutics AG (CRSP) Receivables - Net (2015 - 2024)
CRISPR Therapeutics AG (CRSP) reported Receivables - Net of $25.0 million for Q4 2024, down 87.5% on a YoY basis from $200.0 million in Q1 2024, and down 87.5% sequentially from $200.0 million in Q4 2023.
CRISPR Therapeutics AG (CRSP) Receivables - Net (2015 - 2024) Analysis & Trends
CRISPR Therapeutics AG (CRSP) has 10 years of Receivables - Net data on file, last reported at $25.0 million in Q4 2024.
- For the quarter ending Q4 2024, Receivables - Net fell 87.5% year-over-year to $25.0 million; the trailing twelve-month figure through Dec 2024 stood at $25.0 million (down 87.5% YoY), and the FY2024 full-year result was $25.0 million, down 87.5% from the prior year.
- Receivables - Net slipped to $25.0 million in Q4 2024, from $200.0 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $200.0 million in Q4 2023 to a low of $33000.0 in Q2 2020.
- A 5-year average of $23.0 million and a median of $150000.0 in 2021 frame the typical range for Receivables - Net.
- Across the five-year window, Receivables - Net sank 99.44% in 2020 and jumped 105960.61% in 2023, its largest moves.
- Tracing CRSP's Receivables - Net over 5 years: stood at $144000.0 in 2020, then jumped by 111.81% to $305000.0 in 2021, then sank by 83.93% to $49000.0 in 2022, then soared by 408063.27% to $200.0 million in 2023, then plunged by 87.5% to $25.0 million in 2024.
- Business Quant data shows CRSP's Receivables - Net at $25.0 million in Q4 2024, $200.0 million in Q4 2023, and $70.0 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CRISPR Therapeutics AG | 4.57 Bn | 2.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 25.00 Mn |
| Dec 31, 2024 | 25.00 Mn |
| Dec 31, 2023 | 200.00 Mn |
| Dec 31, 2023 | 200.00 Mn |
| Jun 30, 2023 | 70.00 Mn |
| Jun 30, 2023 | 70.00 Mn |
| Sep 30, 2022 | 49,000.00 |
| Sep 30, 2022 | 49,000.00 |
| Jun 30, 2022 | 66,000.00 |
| Jun 30, 2022 | 66,000.00 |
| Mar 31, 2022 | 143,000.00 |
| Mar 31, 2022 | 143,000.00 |
| Dec 31, 2021 | 305,000.00 |
| Dec 31, 2021 | 305,000.00 |
| Sep 30, 2021 | 152,000.00 |
| Sep 30, 2021 | 152,000.00 |
| Jun 30, 2021 | 150,000.00 |
| Jun 30, 2021 | 150,000.00 |
| Mar 31, 2021 | 150,000.00 |
| Mar 31, 2021 | 150,000.00 |